Tumour regression and survival of patients with disseminated malignant melanoma treated with chemotherapy and specific active immunotherapy.
D000328:Adult; D000951:Antigens, Neoplasm; D001500:BCG Vaccine / Q000627:therapeutic use*; D003606:Dacarbazine / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008175:Lung Neoplasms / Q000628:therapy; D008198:Lymph Nodes; D008297:Male; D008545:Melanoma / Q000628:therapy*; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011379:Prognosis; D012878:Skin Neoplasms / Q000628:therapy; D014226:Triazenes / Q000627:therapeutic use*
D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D014226:Triazenes; D003606:Dacarbazine